🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

sciencedirect.com/science/articl… 🔥 New article from Gemma K Reynolds Beatrice Sim monica slavin Ben Teh Systematic review and meta-analysis of infections in HM patients treated with CAR-T. Bacterial more common than viral or fungal post CAR-T, 17% developed serious infection.

In light of updated MajesTEC-1 data at #IMS23 this week showing infection-related mortality of 12.7%(!), it is timely to see the nicely-formatted version of our systematic review just out in Blood Advances Gemma K Reynolds #mmsm Manni Mohyuddin

Superb and hard work from Tori Hall PhD extraordinaire. Another impactful collab with Kedzierska Lab . Will guide future long acting MoAb Prep practice. #TxID

Thanks for coming to our session. NATASHA HALASA and i had fun with our talks. Hope it was useful! #ESCMIDGlobal2024 #TxID

An amazing nation wide randomised trial of a simple reminder transforming vaccination uptake, even in immune compromised. Elegant solution. #ESCMIDGlobal2024 #TxID

Hot off the press - late breaking data from Tori Hall NCIC demonstrating similiar immunogenicity from two different vax strategies and no incremental benefit of second dose. #ESCMIDGlobal2024 #TxID

#ECCMID2024 Results from RCT of SD vs AD flu vaccine as a strategy for high-risk HM group by Tori Hall NCIC Ben Teh showing no difference in primary outcome seroconversion but highlighting the CLL NHL groups as having poor responses in general. How to improve this?

#ECCMID2024 Hot topic 🔥 of developing AI tools for infection detection. Anna Khanina NCIC NCAS_Australia explaining the laborious manual process and aiming for AI detection. Check out this cool dashboard for fungal infections IFIS!!! Coming soon

Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis [Oct 10, 2023] Gemma K Reynolds et al. Ben Teh Blood Advances ashpublications.org/bloodadvances/… #IDonc #mmsm #caxtx

A global call to encourage the use of standard reporting of infection AEs so we can advance research in the field. It was also mentioned at #ESCMIDGlobal2024

Wonderful work by Gemma K Reynolds queen of systematic rev and meta-analysis!

Congratulations to the 20 new NHMRC’s Centres of Research Excellence that will share in an investment of $60 million announced today. Read our media release on our News Centre: ow.ly/NeRY50T0Nsx

Peter Mac has been awarded 3 significant NHMRC grants totalling $9m to drive forward innovative approaches in #cancer treatment, lymphatic health and antimicrobial stewardship, led by Ben Hogan, monica slavin and Prof Karin Thursky. More 👇 petermac.org/about-us/news-…

Delighted to be part of NCIC monica slavin CRE to reduce the burden of infection in patients on new gen therapies.

Poster presentations in session… presenting influenza-specific B & T cell analyses in pts w/ haematological malignancy - T cell responses preserved & less dependent on underlying disease and treatment regimen received. NCIC Kedzierska Lab Infectious Diseases at Austin Health Ben Teh Options2024

In this trial involving patients with hematologic cancers, the immune responses that were elicited were similar for adjuvanted-dose and standard-dose influenza vaccines. Read the full trial results: nej.md/40ztLNF

Very proud of this hard work by all involved. Limited benefit of adjuvanted flu vaccine vs standard dose and 2 vs 1 doses in patients with myeloma, CLL or NHL. NEJM Peter Mac Cancer Centre NCIC nejm.org/doi/full/10.10…

Optimal vaccination is challenging - especially in ICH pts! New NEJM Tori Hall study assessing flu vax in heme pts: two-dose adjuvanted v standard 💉 Similar seroconversion 💉 Better response in MM, though similar between arms Find it in vax 📁! transplantid.net/55L3SZ5T